Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry

Hsin-An Hou, Yanfang Liu, MD MPH, Hong Qiu, MD PhD, Hwei-Fang Tien, MD, PhD, Chao-Hsiun Tang

Blood (2019) 134 (Supplement_1): 1878.

https://doi.org/10.1182/blood-2019-124296

Published: 2019

Journal Articles

Risk Factors Associated with Earlier Relapse and Death and Treatment Response in Patients with Follicular Lymphoma in Taiwan

Sung-Nan Pei, MD, Kuan-Chih Huang, Ming-Chung Wang, MD, Ching-Yuan Kuo, Ming-Chun Ma, MD, Chun-Kai Liao, MD, Lee Anne Rothwell, PhD, Hong Qiu, MD PhD, Yanfang Liu, MD MPH

Blood (2018) 132 (Supplement 1): 5338.

https://doi.org/10.1182/blood-2018-99-112347

Published: 2018

Journal Articles

An Increasing Trend of Incidence, Prevalence and Mortality, and Occurrence of Second Primary Malignancies Among Patients with B-Cell Non-Hodgkin Lymphoma: A 10-Year Longitudinal Population-Based Retrospective Cohort Study in South Korea

Jin Seok Kim, MD, PhD, Yanfang Liu, MD MPH, Kyoung Hwa Ha, PhD, Hong Qiu, MD PhD, Lee Anne Rothwell, PhD, Yu Ri Kim, MD, Hyeon Chang Kim, MD PhD

Blood (2018) 132 (Supplement 1): 2991.

https://doi.org/10.1182/blood-2018-99-110418

Published: 2018

Journal Articles

Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan

Hsin-An Hou, MD, PhD, Chao-Hsiun Tang, PhD, Hung-Yi Liu, Hong Qiu, MD PhD, Sarah Siggins, PhD, Lee Anne Rothwell, PhD, Ya-Wen Yang, Sung-Nan Pei, MD, Yongjing Zhang, MD PhD, Yanfang Liu, MD MPH

Blood (2017) 130 (Supplement 1): 5434.

https://doi.org/10.1182/blood.V130.Suppl_1.5434.5434

Published: 2017

Journal Articles

Clinical Characteristics and Treatment of Patients with Multiple Myeloma Using the Japan Medical Data Center Database

Sarah Siggins, PhD, Hong Qiu, MD PhD, Yongjing Zhang, MD PhD, Titan Huang, Sung-Nan Pei, MD, Lee Anne Rothwell, PhD, Yanfang Liu, MD MPH

Blood (2017) 130 (Supplement 1): 5421.

https://doi.org/10.1182/blood.V130.Suppl_1.5421.5421

Published: 2017

NARROW

Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry

Risk Factors Associated with Earlier Relapse and Death and Treatment Response in Patients with Follicular Lymphoma in Taiwan

An Increasing Trend of Incidence, Prevalence and Mortality, and Occurrence of Second Primary Malignancies Among Patients with B-Cell Non-Hodgkin Lymphoma: A 10-Year Longitudinal Population-Based Retrospective Cohort Study in South Korea

Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan

Clinical Characteristics and Treatment of Patients with Multiple Myeloma Using the Japan Medical Data Center Database

Email alerts

ASH Publications

American Society of Hematology

Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry

Risk Factors Associated with Earlier Relapse and Death and Treatment Response in Patients with Follicular Lymphoma in Taiwan

An Increasing Trend of Incidence, Prevalence and Mortality, and Occurrence of Second Primary Malignancies Among Patients with B-Cell Non-Hodgkin Lymphoma: A 10-Year Longitudinal Population-Based Retrospective Cohort Study in South Korea

Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan

Clinical Characteristics and Treatment of Patients with Multiple Myeloma Using the Japan Medical Data Center Database

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only